• Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$94.92
+0 (0.00%)
Get New Cerner Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CERN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CERN

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Cerner in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $94.92.

This chart shows the closing price for CERN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Cerner. This rating has held steady since April 2023, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/1/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/28/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/27/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/25/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/23/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/22/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/22/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/11/2022ArgusDowngradeBuy ➝ Hold
12/21/2021Morgan StanleyBoost TargetEqual Weight$85.00 ➝ $95.00
12/20/2021Edward JonesDowngradeBuy ➝ Hold
12/20/2021Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$86.00 ➝ $95.00
12/20/2021Leerink PartnersDowngradeOutperform ➝ Market Perform$88.00 ➝ $95.00
12/20/2021Morgan StanleyUpgradeUnderweight ➝ Equal Weight$77.00 ➝ $85.00
11/16/2021Robert W. BairdInitiated CoverageNeutral$82.00
11/1/2021BarclaysBoost TargetEqual Weight$77.00 ➝ $79.00
10/17/2021Leerink PartnersReiterated RatingBuy
8/31/2021Morgan StanleyBoost TargetUnderweight$70.00 ➝ $75.00
8/2/2021Leerink PartnersBoost TargetOutperform$83.00 ➝ $88.00
7/30/2021Piper SandlerBoost TargetPositive ➝ Overweight$85.00 ➝ $88.00
5/6/2021Leerink PartnersLower TargetOutperform$86.00 ➝ $83.00
2/16/2021Piper SandlerBoost TargetOverweight$84.00 ➝ $85.00
2/11/2021Truist FinancialBoost Target$72.00 ➝ $82.00
2/11/2021Morgan StanleyBoost TargetUnderweight$64.00 ➝ $70.00
2/11/2021KeyCorpBoost TargetOverweight$82.00 ➝ $90.00
2/11/2021UBS GroupDowngradeBuy ➝ Neutral$82.00
1/19/2021Bank of AmericaDowngradeBuy ➝ Underperform
12/29/2020ArgusBoost TargetAverage ➝ Buy$77.00 ➝ $88.00
10/30/2020Piper SandlerBoost TargetOverweight$81.00 ➝ $84.00
10/29/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$77.00 ➝ $79.00
10/29/2020Wells Fargo & CompanyBoost TargetOverweight$81.00 ➝ $82.00
10/29/2020Leerink PartnersBoost TargetOutperform$78.00 ➝ $79.00
8/11/2020Jefferies Financial GroupReiterated RatingBuy$88.00
7/31/2020Morgan StanleyBoost TargetUnderweight$58.00 ➝ $62.00
7/31/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$72.00 ➝ $77.00
7/30/2020Royal Bank of CanadaReiterated RatingBuy$80.00
7/6/2020StephensInitiated CoverageEqual Weight$75.00
5/13/2020Morgan StanleyBoost TargetUnderweight$52.00 ➝ $58.00
5/1/2020SunTrust BanksDowngradeBuy ➝ Hold$66.00 ➝ $72.00
4/29/2020BarclaysLower TargetEqual Weight$72.00 ➝ $67.00
4/29/2020UBS GroupLower TargetBuy$84.00 ➝ $82.00
4/22/2020Jefferies Financial GroupUpgradeHold ➝ Buy$75.00 ➝ $90.00
4/13/2020Leerink PartnersInitiated CoverageOutperform$78.00
3/30/2020CowenUpgradeMarket Perform ➝ Outperform$79.00
3/27/2020Morgan StanleyLower TargetUnderweight$65.00 ➝ $52.00
3/26/2020SunTrust BanksLower TargetPositive ➝ Buy$79.00 ➝ $66.00
3/11/2020Stifel NicolausLower Target$81.00 ➝ $75.00
3/11/2020JPMorgan Chase & Co.Lower TargetNeutral$75.00 ➝ $74.00
3/11/2020SunTrust BanksLower TargetBuy$82.00 ➝ $79.00
3/11/2020UBS GroupReiterated RatingBuy$85.00 ➝ $84.00
2/5/2020Piper SandlerBoost Target$78.00 ➝ $82.00
2/5/2020CfraBoost TargetHold$72.00 ➝ $76.00
2/5/2020SunTrust BanksReiterated RatingBuy
2/5/2020Robert W. BairdBoost TargetOutperform$72.00 ➝ $85.00
1/8/2020Wells Fargo & CompanyBoost TargetOverweight$80.00 ➝ $83.50
(Data available from 12/22/2019 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 10 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
5/26/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
6/25/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
7/25/2024
  • 1 very positive mentions
  • 15 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
8/24/2024
  • 4 very positive mentions
  • 13 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
9/23/2024
  • 1 very positive mentions
  • 25 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
10/23/2024
  • 1 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
11/22/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/22/2024

Current Sentiment

  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Cerner logo
Cerner Corporation, together with its subsidiaries, provides health care information technology solutions and tech-enabled services in the United States and internationally. It offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers. The company also provides HealtheIntent platform, a cloud-based platform to aggregate, transform, and reconcile data across the continuum of care; and CareAware, an EHR agnostic platform that facilitates connectivity of health care devices to EHRs. In addition, it offers a portfolio of clinical and financial healthcare information technology solutions, as well as departmental and care coordination solutions. Further, the company provides tech-enabled services, such as implementation and training, remote hosting, application management, revenue cycle, support and maintenance, health care data analysis, real-world evidence, clinical process optimization, transaction processing, employer health centers, and data-driven services; and complementary hardware and devices for third parties. It serves integrated delivery networks, physician groups and networks, managed care organizations, hospitals, medical centers, free-standing reference laboratories, home health agencies, blood banks, imaging centers, pharmacies, pharmaceutical manufacturers, employers, governments, and public health organizations. The company was founded in 1979 and is headquartered in North Kansas City, Missouri.
Read More

Today's Range

Now: $94.92
Low: $94.92
High: $94.92

50 Day Range

MA: $94.92
Low: $94.92
High: $94.92

52 Week Range

Now: $94.92
Low: $69.08
High: $95.40

Volume

1,320 shs

Average Volume

3,997,693 shs

Market Capitalization

$27.92 billion

P/E Ratio

47.70

Dividend Yield

1.14%

Beta

0.77

Frequently Asked Questions

What sell-side analysts currently cover shares of Cerner?

The following Wall Street research analysts have issued reports on Cerner in the last year: StockNews.com.
View the latest analyst ratings for CERN.

What is the current price target for Cerner?

0 Wall Street analysts have set twelve-month price targets for Cerner in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Cerner in the next year.
View the latest price targets for CERN.

What is the current consensus analyst rating for Cerner?

Cerner currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for CERN.

What other companies compete with Cerner?

Other companies that are similar to Cerner include Omnicell, Veradigm, HealthStream, Cortexyme and GoDaddy. Learn More about companies similar to Cerner.

How do I contact Cerner's investor relations team?

Cerner's physical mailing address is 2800 ROCKCREEK PKWY W0162, NORTH KANSAS CITY MO, 64117. The company's listed phone number is (816) 221-1024 and its investor relations email address is [email protected]. The official website for Cerner is www.cerner.com. Learn More about contacing Cerner investor relations.